Cargando…

Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study

Patients with steroid refractory gastrointestinal (GI) tract graft- vs.-host disease (GvHD) face a poor prognosis and limited therapeutic options. To accurately assess the efficacy and safety of fecal microbiota transplantation (FMT) in treating steroid refractory GI tract GvHD, we conducted a pilot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qi, Xiaofei, Li, Xuewei, Zhao, Ye, Wu, Xiaojin, Chen, Feng, Ma, Xiao, Zhang, Faming, Wu, Depei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167440/ https://www.ncbi.nlm.nih.gov/pubmed/30319644 http://dx.doi.org/10.3389/fimmu.2018.02195

Ejemplares similares

Fecal microbiota transplantation combined with ruxolitinib as a salvage treatment for intestinal steroid-refractory acute GVHD
por: Liu, Yin, et al.
Publicado: (2022)

Fecal microbiota transplantation for steroid-refractory gastrointestinal graft-versus-host disease
por: Kim, Hyun Min, et al.
Publicado: (2023)

Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial
por: Zhao, Ye, et al.
Publicado: (2021)

The Role of Intestinal Microbiota in Acute Graft-versus-Host Disease
por: Chen, Yuanyuan, et al.
Publicado: (2015)

Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis
por: Cui, Bota, et al.
Publicado: (2015)

Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature
por: Biernat, Monika Maria, et al.
Publicado: (2020)

Ruxolitinib in steroid refractory graft-vs.-host disease: a case report
por: Maffini, Enrico, et al.
Publicado: (2016)

Efficiency and Toxicity of Ruxolitinib as a Salvage Treatment for Steroid-Refractory Chronic Graft-Versus-Host Disease
por: Wang, Dong, et al.
Publicado: (2021)

Evaluation of Ruxolitinib for Steroid-Refractory Chronic Graft-vs-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
por: Wu, Hengwei, et al.
Publicado: (2021)

PB2455: THE DARK SIDE OF FECAL MICROBIOTA TRANSPLANTATION IN REFRACTORY ACUTE GASTROINTESTINAL GRAFT VERSUS HOST DISEASE.
por: Hari, Oumayma, et al.
Publicado: (2023)

Murine Models of Steroid Refractory Graft-versus-Host Disease
por: Toubai, Tomomi, et al.
Publicado: (2018)

Pilot study of a new online extracorporeal photopheresis system in patients with steroid refractory or dependent chronic graft vs host disease
por: Radwanski, Katherine, et al.
Publicado: (2020)

2844. Butyrogenic Bacteria After Acute Graft vs. Host Disease Associate with the Development of Steroid Refractory GVHD
por: Golob, Jonathan L, et al.
Publicado: (2019)

Fecal Microbiota Transplantation for Treatment of Acute Graft-versus-Host Disease
por: Shouval, Roni, et al.
Publicado: (2019)

High stearic acid diet modulates gut microbiota and aggravates acute graft-versus-host disease
por: Yang, Bingyu, et al.
Publicado: (2021)

Intramesenteric Steroid Treatment for Steroid- Refractory Gastrointestinal Graft Versus Host Disease
por: Bilgin, Aynur Uğur, et al.
Publicado: (2012)

The Role of Fecal Microbiota Transplantation in the Treatment of Acute Graft-versus-Host Disease
por: Biliński, Jarosław, et al.
Publicado: (2022)

Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report
por: Mao, Dan, et al.
Publicado: (2020)

Fecal microbiota transplantation for refractory Crohn's disease
por: Bak, Seon Ho, et al.
Publicado: (2017)

Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
por: Zhang, Ting, et al.
Publicado: (2020)

Treatment of Severe Steroid-Refractory Acute-Graft-vs.-Host Disease With Mesenchymal Stem Cells–Single Center Experience
por: Česen Mazič, Maja, et al.
Publicado: (2018)

Experimental Pharmaceuticals for Steroid-Refractory Acute Graft-versus-Host Disease
por: Abedin, Sameem, et al.
Publicado: (2020)

Extracorporeal photopheresis vs standard therapies for steroid‐refractory chronic graft‐vs‐host disease: Pharmacoeconomic assessment of hospital resource use in Spain
por: Boluda, Blanca, et al.
Publicado: (2021)

Treatment and unmet needs in steroid-refractory acute graft-versus-host disease
por: Malard, Florent, et al.
Publicado: (2020)

Step-up fecal microbiota transplantation (FMT) strategy
por: Cui, Bota, et al.
Publicado: (2016)

Case report: Fecal microbiota transplantation in refractory ankylosing spondylitis
por: Wang, Lei, et al.
Publicado: (2023)

IL-17C Mitigates Murine Acute Graft-vs.-Host Disease by Promoting Intestinal Barrier Functions and Treg Differentiation
por: Gong, Huanle, et al.
Publicado: (2018)

Late Onset and Protracted Course of Steroid Refractory Chronic Graft-versus-Host Disease
por: Gunes, Gursel, et al.
Publicado: (2015)

Combination of bortezomib plus ruxolitinib in steroid-refractory chronic graft-versus-host disease
por: Kaloyannidis, Panayotis, et al.
Publicado: (2018)

Steroid-refractory chronic graft-versus-host disease: treatment options and patient management
por: Wolff, Daniel, et al.
Publicado: (2021)

The interplay of gut microbiota between donors and recipients determines the efficacy of fecal microbiota transplantation
por: He, Ruiqiao, et al.
Publicado: (2022)

Restoration of the Original Inhabitants: A Systematic Review on Fecal Microbiota Transplantation for Graft-Versus-Host Disease
por: Alabdaljabar, Mohamad S., et al.
Publicado: (2022)

Etanercept for steroid-refractory acute graft versus host disease following allogeneic hematopoietic stem cell transplantation
por: Park, Joo Han, et al.
Publicado: (2014)

Improvement of Good’s syndrome by fecal microbiota transplantation: the first case report
por: Jagessar, Sabreen Abdul Rahman, et al.
Publicado: (2019)

Fecal microbiota transplantation in refractory ulcerative colitis – a case report
por: Moutinho, B. D., et al.
Publicado: (2019)

Mesenchymal Stem Cell Treatment for Steroid Refractory Graft-versus-Host Disease in Children: A Pilot and First Study from Turkey
por: Erbey, Fatih, et al.
Publicado: (2016)

Encyclopedia of fecal microbiota transplantation: a review of effectiveness in the treatment of 85 diseases
por: Wang, Yun, et al.
Publicado: (2022)

Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease
por: Zhang, Fen, et al.
Publicado: (2021)

Etanercept for steroid-refractory acute graft-versus-host disease: A single center experience
por: De Jong, Cornelis N., et al.
Publicado: (2017)

Efficacy and safety of ruxolitinib in steroid-refractory graft-versus-host disease: A meta-analysis
por: Fan, Shuang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_1rvtvq73gqrar70kk1rl75qo3f